Sefer Gezer to Myelodysplastic Syndromes
This is a "connection" page, showing publications Sefer Gezer has written about Myelodysplastic Syndromes.
Connection Strength
0.621
-
Remicade as TNF suppressor in patients with myelodysplastic syndromes. Leuk Lymphoma. 2004 Oct; 45(10):2099-104.
Score: 0.060
-
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Leuk Res. 2004 Aug; 28(8):791-803.
Score: 0.060
-
The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes. Br J Haematol. 2001 Dec; 115(4):881-94.
Score: 0.050
-
Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes. Leuk Res. 2001 Nov; 25(11):941-54.
Score: 0.049
-
Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes. Blood. 2001 Aug 15; 98(4):958-65.
Score: 0.049
-
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone. Blood. 2000 Mar 01; 95(5):1580-7.
Score: 0.044
-
Biologic characteristics of patients with hypocellular myelodysplastic syndromes. Leuk Res. 1999 Apr; 23(4):357-64.
Score: 0.041
-
Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis. Eur J Haematol. 1999 Feb; 62(2):90-4.
Score: 0.041
-
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine. Exp Hematol. 1997 Jun; 25(6):530-5.
Score: 0.036
-
Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res. 1996 Nov-Dec; 20(11-12):891-900.
Score: 0.035
-
Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood. 1996 Oct 01; 88(7):2640-7.
Score: 0.035
-
A paradigm shift in myelodysplastic syndromes. Leukemia. 1996 Oct; 10(10):1648-52.
Score: 0.035
-
Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines. Int J Hematol. 1996 Jun; 63(4):265-78.
Score: 0.034
-
Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 1995 Jul 01; 86(1):268-76.
Score: 0.032
-
Detection of monosomy 7 in interphase cells of patients with myeloid disorders. Am J Hematol. 1990 Feb; 33(2):117-22.
Score: 0.022